Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Cappello

Showing results (81-90 of 88) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 88 results.
Proceedings of the National Academy of Sciences of the United States of America|March 5, 1996
Anticoagulant repertoire of the hookworm Ancylostoma caninumP Stassens, P W Bergum, Y Gansemans, et al.
Scientific Reports|February 3, 2017
Alexithymia and personality traits of patients with inflammatory bowel diseaseD La Barbera, B Bonanno, M V Rumeo, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Health-Related Quality of Life in Italian Patients With Moderate and Severe Crohn's Disease: Interim Results from the Sole StudyC Lazzaro, M Cappello, C Cortelezzi, et al.
Alimentary Pharmacology & Therapeutics|August 19, 2007
Infliximab in severe ulcerative colitis: short-term results of different infusion regimens and long-term follow-upA Kohn, M Daperno, A Armuzzi, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
A Health Technology-Related Cost Description Concerning Italian Ibd Centres Dealing With Crohn's Disease Results From Sole StudyC Lazzaro, M Cappello, C Cortelezzi, et al.
European Review for Medical and Pharmacological Sciences|November 20, 2020
Azathioprine for prevention of clinical recurrence in Crohn's disease patients with severe endoscopic recurrence: an IG-IBD randomized double-blind trialA Orlando, F Mocciaro, M Ventimiglia, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 13, 2023
Golimumab improves health-related quality of life of patients with moderate-to-severe ulcerative colitis: Results of the go-care studyS Saibeni, C Bezzio, F Bossa, et al.
ESMO Open|July 6, 2024
A 1-year follow-up study on checkpoint inhibitor-induced colitis: results from a European consortiumM V Lenti, D G Ribaldone, F Borrelli de Andreis, et al.
Pageof 9

Showing results (81-90 of 88) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 88 results.
Proceedings of the National Academy of Sciences of the United States of America|March 5, 1996
Anticoagulant repertoire of the hookworm Ancylostoma caninumP Stassens, P W Bergum, Y Gansemans, et al.
Scientific Reports|February 3, 2017
Alexithymia and personality traits of patients with inflammatory bowel diseaseD La Barbera, B Bonanno, M V Rumeo, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Health-Related Quality of Life in Italian Patients With Moderate and Severe Crohn's Disease: Interim Results from the Sole StudyC Lazzaro, M Cappello, C Cortelezzi, et al.
Alimentary Pharmacology & Therapeutics|August 19, 2007
Infliximab in severe ulcerative colitis: short-term results of different infusion regimens and long-term follow-upA Kohn, M Daperno, A Armuzzi, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
A Health Technology-Related Cost Description Concerning Italian Ibd Centres Dealing With Crohn's Disease Results From Sole StudyC Lazzaro, M Cappello, C Cortelezzi, et al.
European Review for Medical and Pharmacological Sciences|November 20, 2020
Azathioprine for prevention of clinical recurrence in Crohn's disease patients with severe endoscopic recurrence: an IG-IBD randomized double-blind trialA Orlando, F Mocciaro, M Ventimiglia, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 13, 2023
Golimumab improves health-related quality of life of patients with moderate-to-severe ulcerative colitis: Results of the go-care studyS Saibeni, C Bezzio, F Bossa, et al.
ESMO Open|July 6, 2024
A 1-year follow-up study on checkpoint inhibitor-induced colitis: results from a European consortiumM V Lenti, D G Ribaldone, F Borrelli de Andreis, et al.
Pageof 9